Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease.The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Deep brain stimulation (DBS) has been instrumental in managing Parkinson's symptoms for over three decades. Medtronic's Percept™ DBS neurostimulators now incorporate BrainSense™ Adaptive ...

Despite its benefits, placement of DBS is not without risks (Medtronic, Inc., 2000). The Summary of Safety and Effectiveness Data for Supplemental Premarket Approval Application to the U.S. Food ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology †, introducing aDBS for people living with Parkinson's. This feature personalizes ...